WHC is still in active development. Read this to understand our approach.
depiction of OZYUPQUCAUTOBP-UHFFFAOYSA-N.svg
isomerdesign

Levallorphan

Check on isomerdesign

pubchem

Levallorphan

Check on pubchem

drugmap

Levallorphan

Check on drugmap

wiki

Levallorphan

Check on wiki

wiki

Dextrallorphan

Check on wiki

Data

InChI: InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2

Synonyms: Morphinan-3-ol, 17-allyl-, (-)-,353613BU4U,Levallorphanum [INN-Latin],Tox21_112005,CAS-152-02-3, L-N-Allyl-3-hydroxymorphinan,DSSTox_GSID_23205,Ro-1-7700,HSDB 2148,(-)-3-Hydroxy-N-allylmorphinan, Levallorphanum,Levallorphane,NCGC00162247-02,LEVALLORPHAN [MI], Levalorfano, (-)-3-Hydroxy-N-allylmorphinan,LEVALLORPHAN [HSDB],CHEMBL1254682,ZINC3875992,(-)-17-allylmorphinan-3-ol,BDBM50326673,(a^?-17-allylmorphinan-3-ol,Levo-3-hydroxy-N-allyl morphinan,152-02-3, Levallorphanum [INN-Latin], 17-prop-2-en-1-ylmorphinan-3-ol, Naloxiphan,Q6534827, Levallorphan [INN:BAN],levallorphan, Ro-1-7700,Levalorfano,EN300-19767758,Levallorphane [INN-French],17-prop-2-en-1-ylmorphinan-3-ol,LEVALLORPHAN [INN],Lorfan,(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-trien-4-ol,17-allyl-(1R,9R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol( Levallorphan),EINECS 205-799-1,C07069,Levallofano,Levallofano [DCIT],(1R,9R,10R)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol,Tox21_112005_1,Morphinan, 17-allyl-3-hydroxy-,UNII-353613BU4U, N-Allyl-3-hydroxymorphinan,Levallorphanum,DSSTox_CID_3205, 17-Allylmorphinan-3-ol,(levallorphan)17-allyl-(1R,9R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol,DB00504, Levallorphane [INN-French],Levallorphan [INN:BAN],LEVALLORPHAN [WHO-DD],N-Allyl-3-hydroxymorphinan,SCHEMBL34060,17-Allylmorphinan-3-ol,CHEBI:6431,Morphinan-3-ol, 17-allyl-,NCGC00162247-06,Levalorfano [INN-Spanish],Levallorphan, Lorfan (TN),L-N-Allyl-3-hydroxymorphinan, Levo-3-hydroxy-N-allyl morphinan, Levallofano [DCIT],Naloxiphan, Levalorfano [INN-Spanish],DTXSID9023205,GTPL7209,17-allyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (Levallorphan),DSSTox_RID_76925, Levallorphane

Estimated data

Solubility: -3.685 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 97.5% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.